Amyotrophic Lateral Sclerosis
FY25 Therapeutic Development Award
The list of Fiscal Year 2025 Amyotrophic Lateral Sclerosis Research Program Therapeutic Development Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
| Institution | Principal Investigator |
|---|---|
| National Institute of Neurological Disorders and Stroke | Avindra Nath |
| Modulo Bio, Inc. | Ryan Lim |
| Transposon Therapeutics, Inc. | Michael Cordingley |
Last updated Tuesday, January 6, 2026